Chat with us, powered by LiveChat Need help with week 1, reply to student 2 discussion writing MCsebasco | Economics Write
+1(978)310-4246 credencewriters@gmail.com
  

Open file to follow instructions.it is to reply 1 page long to student 2. This time read the student discussion writing about high cost of prescription medication from pharmaceutical industrial.
reply_to_the_student_2.docx

nurs_6050_policy_and_advocacy_for_improving_population_health_week_1_instructions..docx

Unformatted Attachment Preview

REPLY TO THE STUDENT 2
The impact of high drug costs in the United States has affected the population in various ways.
For years and even currently, high drug costs have been problematic for citizens that require a
need for medications. President Donald Trump, Barack Obama, and George W. Bush all have
emphasized reasonings as to why they believe the cost of prescription drugs have been on a rise.
President Donald Trump’s views on high drug costs were related to the United States
being overcharged for medications in comparison to foreign countries. In the words of President
Trump, “For decades, other countries have rigged the system so that American patients are
charged much more — and in some cases much, much more — for the exact same drug”
(Whitehouse.gov, 2018). It was also mentioned that pharmacists were not able to inform
consumers of an alternative medication for a cheaper price, so therefore consumers were
not aware of alternative medications being available for a cheaper price. In order to help combat
the issues of high drug costs, President Trump signed two bills to help lower the cost of
prescription drugs and granted authority for the Department of Human Health Services to allow
Medicare to determine the price it pays for certain drugs, based upon prices paid by other
nations. The two bills signed were the Know the Lowest Price Act and the Patient Right to Know
Act. The bills provided consumers with the knowledge of how to obtain more affordable
prescriptions in order to treat their health issues and to not neglect their health treatment due to
high drug pricing. The bills also allowed the pharmacists authority to discuss cheaper alternative
medications for patients.
Former President Barack Obama’s views on high drug costs were related to
pharmaceutical companies being more concerned for profit off of a medication instead of
companies being able to provide medications at an affordable cost for consumers. Former
President Barack Obama stated that, “The pharmaceutical industry oppose(d) any change to drug
pricing, no matter how justifiable and modest, because they believe it threatens their profits”
(Statenews.com, 2016). In efforts to combat the issues of high drug costs due to pharmaceutical
companies not willing to implement medication price change, Obamacare was created in
2010. According to a Centers for Medicare and Medicaid Services press release from 2017,
Medicare beneficiaries have saved over $26.8 billion on prescription drugs under Obamacare
(Healthline.com, 2019). Obamacare allowed consumers to save on drug costs.
As stated by former president George W. Bush, “The best way to control rising drug
costs, while preserving the innovation that will result in future cures for diseases, is through
greater competition and price transparency” (nejm.org, 2004). Bush promoted for the use of
generic drugs as they were more affordable than brand-name drugs. Former President Bush, also
indicated that, “Pharmaceutical companies were exploiting to block competition from genericdrug manufacturers” (nejm.org, 2004). Being able to present consumers with an option of a
generic drug or a brand name drug, stands between the difference of individuals being able to be
compliant or noncompliant with their treatment plan in order to better their health.
In conclusion, various things have affected the high drug costs in America. Some of the
things that has affected this ongoing issue is being overcharged for medications in comparison to
foreign countries, pharmaceutical companies being more concerned for profit off of a
medication, and pharmaceutical companies blocking generic-drug manufactures. The actions put
in place by all three presidents has impacted the high drug cost issue by improving the price of
drug costs in multiple ways.
References:
@Pharmalot, E. S., Silverman, E., Columnist, A. T., Columnist, E. S., Says:, E. B., & Says:,
P. (2018, April 19). Obama blames high drug prices on firms’ tunnel vision on profits. Retrieved
September 1, 2020, from https://www.statnews.com/pharmalot/2016/07/11/obama-pharmadrug-prices/
Bush, G. W., A. L. Wyllie and Others, L. A. Jackson and Others, & M. Slaoui and M.
Hepburn. (2005, January 27). Health Care Coverage and Drug Costs – The Candidates Speak
Out:NEJM. Retrieved September 1, 2020,
from https://www.nejm.org/doi/full/10.1056/NEJMp048272
Remarks by President Trump on Prescription Drug Prices. (n.d.). Retrieved September 1,
2020, from https://www.whitehouse.gov/briefings-statements/remarks-president-trumpprescription-drug-prices/
Roland, J. (2019, August 17). The Pros and Cons of Obamacare. Retrieved September 1,
2020, from https://www.healthline.com/health/consumer-healthcare-guide/pros-and-consobamacare#cons
NURS 6050 Policy and Advocacy for Improving Population Health
REPLY TO ONE STUDENT DISCUSSION – Week 1

Presidential Agendas”
Regardless of political affiliation, every citizen has a stake in healthcare policy decisions.
Hence, it is little wonder why healthcare items become such high-profile components of
presidential agendas. It is also little wonder why they become such hotly debated agenda
items.
To Prepare:


Review the Resources and reflect on the importance of agenda setting.
Consider how federal agendas promote healthcare issues and how these healthcare issues
become agenda priorities.
By Day 3 of Week 1
Post your response to the discussion question: Consider a topic that rises to
the presidential level. How did each of the presidents (Trump, Obama, and
Bush) handle the problem? What would you do differently? “ATTENTION
REPLY TO STUDENT DISCUSSION THIS TIME> YOU NEED TO CITE THE
REPLY AND PROVIDE REFERENCES AT LEAST 3. “
RESOURCES/REFERENCES
Required Readings
Milstead, J. A., & Short, N. M. (2019). Health policy and politics: A nurse’s guide (6th ed.).
Burlington, MA: Jones & Bartlett Learning.
• Chapter 1, “Informing Public Policy: An Important Role for Registered Nurses” (pp.
11–13 only)
• Chapter 2, “Agenda Setting: What Rises to a Policymaker’s Attention?” (pp. 17–36)
• Chapter 10, “Overview: The Economics and Finance of Health Care” (pp. 171–180)
• Chapter 12, “An Insider’s Guide to Engaging in Policy Activities”
o “Creating a Fact Sheet” (pp. 217-221)
DeMarco, R., & Tufts, K. A. (2014). The mechanics of writing a policy brief. Nursing Outlook,
62(3), 219–224. doi:10.1016/j.outlook.2014.04.002
Note: You will access this article from the Walden Library databases.
Kingdon, J. W. (2001). A model of agenda-setting, with applications. Law Review, M.S.U.D.C.L., 2(331).
Note: You will access this article from the Walden Library databases.
Lamb, G., Newhouse, R., Beverly, C., Toney, D. A., Cropley, S., Weaver, C. A., Kurtzman, E., …
Peterson, C. (2015). Policy agenda for nurse-led care coordination. Nursing Outlook, 63(4),
521–530. doi:10.1016/j.outlook.2015.06.003
Note: You will access this article from the Walden Library databases.
O’Rourke, N. C., Crawford, S. L., Morris, N. S., & Pulcini, J. (2017). Political efficacy and
participation of nurse practitioners. Policy, Politics, and Nursing Practice, 18(3), 135–148.
doi:10.1177/1527154417728514
Note: You will access this article from the Walden Library databases.
Institute of Medicine (US) Committee on Enhancing Environmental Health Content in
Nursing Practice, Pope, A. M., Snyder, M. A., & Mood, L. H. (Eds.). (n.d.). Nursing health, &
environment: Strengthening the relationship to improve the public’s health. Retrieved
September 20, 2018.
USA.gov. (n.d.). A-Z index of U.S. government departments and agencies. Retrieved
September 20, 2018, from https://www.usa.gov/federal-agencies/a
USA.gov. (n.d.). Executive departments. Retrieved September 20, 2018, from
https://www.usa.gov/executive-departments
The White House. (n.d.). The cabinet. Retrieved September 20, 2018, from
https://www.whitehouse.gov/the-trump-administration/the-cabinet/
USA.gov. (n.d.). Executive departments. Retrieved September 20, 2018, from
https://www.usa.gov/executive-departments
The White House. (n.d.). The cabinet. Retrieved September 20, 2018, from
https://www.whitehouse.gov/the-trump-administration/the-cabinet/

Purchase answer to see full
attachment

error: Content is protected !!